TP05

· Tillotts Pharma AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TP05, covering 2018-08-08 to 2018-08-08. Get the full timeline:

Most recent: Clinical Trial Update: TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC) [Phase 3]